Analyst Ratings for Eyegate Pharmaceuticals (EYEG)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/21/2020 | Alliance Global Partners » Updated 8/17/2021 |
Ben Haynor | New Coverage | Buy (N/A) |
9.50 (10.75) |
4.87 (35.59) |
630.8% | Details |
| 4/7/2016 | Noble Capital | N/A | New Coverage | Outperform (N/A) |
10.00 (N/A) |
3.00 (35.59) |
1086.33% | Details |
![]() |
||||||||
![]() |
||||||||


